Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts-Reference-Cited by-同舟云学术

Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts

Published:2008 Issue:2 Volume:14 Page:240-244
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Singh Nina,Wannstedt Cheryl,Keyes Lois,Mayher Debra,Tickerhoof Lisa,Akoad Mohamed,Wagener Marilyn M.,Cacciarelli Thomas V.

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference17 articles.

1. Cytomegalovirus Infection Following Liver Transplantation: Review of the Literature

2. Coronary artery disease after heart transplantation and its relation to cytomegalovirus

3. AN ASSOCIATION BETWEEN CYTOMEGALOVIRUS INFECTION AND CHRONIC REJECTION AFTER LIVER TRANSPLANTATION

4. The Independent Role of Cytomegalovirus as a Risk Factor for Invasive Fungal Disease in Orthotopic Liver Transplant Recipients

5. Primary Cytomegalovirus Infection in Liver Transplant Recipients: Comparison of Infections Transmitted Via Donor Organs and Via Transfusions

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients;Transplant Infectious Disease;2024-06

2. The next frontier: cytomegalovirus antiviral stewardship programs in solid organ transplant;Current Opinion in Infectious Diseases;2023-10-10

3. Part I: PSAP Live: Updates from 2022 Book 1 (Cardiology);JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-10

4. Real world effectiveness and feasibility of pharmacist‐led preemptive CMV treatment in high risk (CMV D+R−) liver transplant;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-07-16

5. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors;JAMA;2020-04-14